Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode

Completed · Phase 3 · Has a placebo group

Conditions studied: Bipolar Disorder

In brief

The purpose of this study is to evaluate flexible doses (5-30mg) of aripiprazole versus placebo in patients with bipolar depression.

Key facts

Study ID
NCT00080314
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
People needed
400
Starts
2004-01-01
Expected to finish
2006-10-01
Last updated by the study team
2013-11-11

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.